• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤演进:达尔文和拉马克式体细胞(无突变)进化中的机遇与必然。

Tumor progression: chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution.

机构信息

Institute for Systems Biology, 401 Terry Avenue North, Seattle, WA 98109, USA.

出版信息

Prog Biophys Mol Biol. 2012 Sep;110(1):69-86. doi: 10.1016/j.pbiomolbio.2012.05.001. Epub 2012 May 11.

DOI:10.1016/j.pbiomolbio.2012.05.001
PMID:22579660
Abstract

Current investigation of cancer progression towards increasing malignancy focuses on the molecular pathways that produce the various cancerous traits of cells. Their acquisition is explained by the somatic mutation theory: tumor progression is the result of a neo-Darwinian evolution in the tissue. Herein cells are the units of selection. Random genetic mutations permanently affecting these pathways create malignant cell phenotypes that are selected for in the disturbed tissue. However, could it be that the capacity of the genome and its gene regulatory network to generate the vast diversity of cell types during development, i.e., to produce inheritable phenotypic changes without mutations, is harnessed by tumorigenesis to propel a directional change towards malignancy? Here we take an encompassing perspective, transcending the orthodoxy of molecular carcinogenesis and review mechanisms of somatic evolution beyond the Neo-Darwinian scheme. We discuss the central concept of "cancer attractors" - the hidden stable states of gene regulatory networks normally not occupied by cells. Noise-induced transitions into such attractors provide a source for randomness (chance) and regulatory constraints (necessity) in the acquisition of novel expression profiles that can be inherited across cell divisions, and hence, can be selected for. But attractors can also be reached in response to environmental signals - thus offering the possibility for inheriting acquired traits that can also be selected for. Therefore, we face the possibility of non-genetic (mutation-independent) equivalents to both Darwinian and Lamarckian evolution which may jointly explain the arrow of change pointing toward increasing malignancy.

摘要

目前对癌症向恶性程度增加的进展的研究集中在产生细胞各种癌变特征的分子途径上。这些途径的获得可以用体细胞突变理论来解释:肿瘤的进展是组织中新达尔文进化的结果。在这里,细胞是选择的单位。随机的遗传突变会永久性地影响这些途径,从而产生恶性细胞表型,在紊乱的组织中被选择。然而,基因组及其基因调控网络在发育过程中产生细胞类型多样性的能力——即在没有突变的情况下产生可遗传的表型变化——是否被肿瘤发生所利用,以推动向恶性程度的定向变化呢?在这里,我们采取了一种全面的观点,超越了分子致癌作用的正统观念,回顾了超越新达尔文主义方案的体细胞进化机制。我们讨论了“癌症吸引子”的核心概念——基因调控网络的隐藏稳定状态,通常细胞不会占据这些状态。噪声诱导的向这些吸引子的转变为获得新的表达谱提供了随机性(机会)和调控约束(必要性)的来源,这些表达谱可以在细胞分裂中遗传,因此可以被选择。但是吸引子也可以响应环境信号而达到——从而提供了继承获得的特征的可能性,这些特征也可以被选择。因此,我们面临着非遗传(独立于突变)的达尔文式和拉马克式进化的可能性,这些进化可能共同解释了指向恶性程度增加的变化方向。

相似文献

1
Tumor progression: chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution.肿瘤演进:达尔文和拉马克式体细胞(无突变)进化中的机遇与必然。
Prog Biophys Mol Biol. 2012 Sep;110(1):69-86. doi: 10.1016/j.pbiomolbio.2012.05.001. Epub 2012 May 11.
2
Genetic and non-genetic instability in tumor progression: link between the fitness landscape and the epigenetic landscape of cancer cells.肿瘤进展中的遗传和非遗传不稳定性:癌细胞适应性景观与表观遗传景观之间的联系。
Cancer Metastasis Rev. 2013 Dec;32(3-4):423-48. doi: 10.1007/s10555-013-9435-7.
3
Reconciling Non-Genetic Plasticity with Somatic Evolution in Cancer.癌症中非遗传可塑性与体细胞进化的调和。
Trends Cancer. 2021 Apr;7(4):309-322. doi: 10.1016/j.trecan.2020.12.007. Epub 2021 Feb 1.
4
Environmental Epigenetics and a Unified Theory of the Molecular Aspects of Evolution: A Neo-Lamarckian Concept that Facilitates Neo-Darwinian Evolution.环境表观遗传学与进化分子层面的统一理论:一种促进新达尔文主义进化的新拉马克主义概念。
Genome Biol Evol. 2015 Apr 26;7(5):1296-302. doi: 10.1093/gbe/evv073.
5
An evolutionary model of carcinogenesis.一种癌症发生的进化模型。
Cancer Res. 2003 Oct 1;63(19):6212-20.
6
The Yin and Yang of anti-Darwinian epigenetics and Darwinian genetics.反达尔文表观遗传学与达尔文遗传学的阴阳之道。
Riv Biol. 2007 Sep-Dec;100(3):361-402.
7
Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.癌症中的遗传和表观遗传异质性:以基因组为中心的视角
J Cell Physiol. 2009 Sep;220(3):538-47. doi: 10.1002/jcp.21799.
8
On the intrinsic inevitability of cancer: from foetal to fatal attraction.论癌症的内在必然性:从胎儿到致命吸引。
Semin Cancer Biol. 2011 Jun;21(3):183-99. doi: 10.1016/j.semcancer.2011.05.003. Epub 2011 May 26.
9
Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer.突变、进化以及自我定义的适合度函数在癌症发生和进展中的核心作用。
Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):162-166. doi: 10.1016/j.bbcan.2017.03.005. Epub 2017 Mar 21.
10
Cell biology, molecular embryology, Lamarckian and Darwinian selection as evolvability.细胞生物学、分子胚胎学、作为可进化性的拉马克式与达尔文式选择。
Genet Mol Res. 2003 Mar 31;2(1):7-28.

引用本文的文献

1
Chromatin-based memory as a self-stabilizing influence on cell identity.基于染色质的记忆对细胞身份的自我稳定影响。
Genome Biol. 2024 Dec 30;25(1):320. doi: 10.1186/s13059-024-03461-x.
2
Estimating the Number of Polygenic Diseases Among Six Mutually Exclusive Entities of Non-Tumors and Cancer.估计六种非肿瘤和癌症相互排斥实体中的多基因疾病数量。
Int J Mol Sci. 2024 Nov 7;25(22):11968. doi: 10.3390/ijms252211968.
3
Graphene-Based Photodynamic Therapy and Overcoming Cancer Resistance Mechanisms: A Comprehensive Review.基于石墨烯的光动力疗法及克服癌症耐药机制:全面综述。
Int J Nanomedicine. 2024 Jun 11;19:5637-5680. doi: 10.2147/IJN.S461300. eCollection 2024.
4
Transcriptional state dynamics lead to heterogeneity and adaptive tumor evolution in urothelial bladder carcinoma.转录状态动态导致尿路上皮膀胱癌的异质性和适应性肿瘤进化。
Commun Biol. 2023 Dec 21;6(1):1292. doi: 10.1038/s42003-023-05668-3.
5
Exploring tumor-normal cross-talk with TranNet: Role of the environment in tumor progression.探讨 TranNet 中的肿瘤-正常细胞串扰:环境在肿瘤进展中的作用。
PLoS Comput Biol. 2023 Sep 18;19(9):e1011472. doi: 10.1371/journal.pcbi.1011472. eCollection 2023 Sep.
6
How Can the Microbiome Induce Carcinogenesis and Modulate Drug Resistance in Cancer Therapy?微生物组如何诱导癌症发生和调节癌症治疗中的药物耐药性?
Int J Mol Sci. 2023 Jul 24;24(14):11855. doi: 10.3390/ijms241411855.
7
A non-mutated fingerprint in cancer genetics.癌症遗传学中的一种非突变指纹。
Front Oncol. 2023 Jun 29;13:1151090. doi: 10.3389/fonc.2023.1151090. eCollection 2023.
8
Exploring tumor-normal cross-talk with TranNet: role of the environment in tumor progression.利用TranNet探索肿瘤与正常组织的相互作用:环境在肿瘤进展中的作用
bioRxiv. 2023 Feb 24:2023.02.24.529899. doi: 10.1101/2023.02.24.529899.
9
miR-23b-3p, miR-124-3p and miR-218-5p Synergistic or Additive Effects on Cellular Processes That Modulate Cervical Cancer Progression? A Molecular Balance That Needs Attention.miR-23b-3p、miR-124-3p 和 miR-218-5p 对调节宫颈癌进展的细胞过程是否具有协同或相加作用?需要关注的分子平衡。
Int J Mol Sci. 2022 Nov 4;23(21):13551. doi: 10.3390/ijms232113551.
10
Small Non-Coding RNAs in Human Cancer.人类癌症中的小型非编码 RNA。
Genes (Basel). 2022 Nov 9;13(11):2072. doi: 10.3390/genes13112072.